93 7440 (Divalproex sodium delayed-release 250 mg)
Pill imprint 93 7440 has been identified as Divalproex sodium delayed-release 250 mg.
Divalproex sodium is used in the treatment of bipolar disorder; mania; migraine prevention; epilepsy; cyclothymic disorder (and more), and belongs to the drug class fatty acid derivative anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Divalproex sodium 250 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for 93 7440 (Divalproex sodium delayed-release 250 mg)
- Imprint:
-
93 7440
- Strength:
- 250 mg
- Color:
- Orange
- Size:
- 15.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Fatty acid derivative anticonvulsants
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Teva Pharmaceuticals USA
- National Drug Code (NDC):
- 00093-7440
- Inactive Ingredients:
- crospovidone
hypromellose
ferrosoferric oxide
lactose monohydrate
magnesium stearate
microcrystalline cellulose
butyl alcohol
polyethylene glycol
polyvinyl alcohol
povidone
corn starch
silicon dioxide
magnesium silicate
titanium dioxide
triethyl citrate
propylene glycol
soya lecithin
FD&C Blue No. 2
ferric oxide red
ferric oxide yellow
More resources
Divalproex sodium delayed-release is associated with the treatment of:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...
